SLC14A2 and ovarian cancer: Furthermore, SLC14A2, which was significantly higher in both BoAA and Caucasian tumours compared to Asian cases has been shown to be down-regulated in chemotherapy-resistant ovarian cancer cell lines [28], suggesting potential race-specific targets for treatment.